Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Dentone

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|July 9, 2022
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 DonorsAlison Tarke, Marina Potesta, Stefania Varchetta, et al.
The Journal of Infection|January 10, 2015
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrastsGiovanni Cenderello, Victoria Tittle, Ambra Pasa, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administrationRaffaella Rosso, Antonio Di Biagio, Chiara Dentone, et al.
AIDS (London, England)|July 18, 2015
Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremiaAmélie Guihot, Chiara Dentone, Lambert Assoumou, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|April 25, 2021
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admissionSamir Giuseppe Sukkar, Ludovica Cogorno, Livia Pisciotta, et al.
European Journal of Clinical Investigation|July 25, 2020
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infectionLucia Taramasso, Antonio Di Biagio, Malgorzata Mikulska, et al.
HIV Clinical Trials|September 15, 2015
Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous systemChiara Dentone, Daniela Fenoglio, Eva Schenone, et al.
Infection and Drug Resistance|June 20, 2019
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA projectPaola Bagella, Nicola Squillace, Elena Ricci, et al.
Infection and Drug Resistance|August 9, 2020
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World CohortPaolo Bonfanti, Andrea De Vito, Elena Ricci, et al.
Microorganisms|December 19, 2020
Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme ElevationsLucia Taramasso, Antonio Vena, Francesca Bovis, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|July 9, 2022
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 DonorsAlison Tarke, Marina Potesta, Stefania Varchetta, et al.
The Journal of Infection|January 10, 2015
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrastsGiovanni Cenderello, Victoria Tittle, Ambra Pasa, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administrationRaffaella Rosso, Antonio Di Biagio, Chiara Dentone, et al.
AIDS (London, England)|July 18, 2015
Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremiaAmélie Guihot, Chiara Dentone, Lambert Assoumou, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|April 25, 2021
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admissionSamir Giuseppe Sukkar, Ludovica Cogorno, Livia Pisciotta, et al.
European Journal of Clinical Investigation|July 25, 2020
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infectionLucia Taramasso, Antonio Di Biagio, Malgorzata Mikulska, et al.
HIV Clinical Trials|September 15, 2015
Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous systemChiara Dentone, Daniela Fenoglio, Eva Schenone, et al.
Infection and Drug Resistance|June 20, 2019
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA projectPaola Bagella, Nicola Squillace, Elena Ricci, et al.
Infection and Drug Resistance|August 9, 2020
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World CohortPaolo Bonfanti, Andrea De Vito, Elena Ricci, et al.
Microorganisms|December 19, 2020
Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme ElevationsLucia Taramasso, Antonio Vena, Francesca Bovis, et al.
Pageof 9